A hybrid genipin-crosslinked dual-sensitive hydrogel/nanostructured lipid carrier ocular drug delivery platform
A hybrid genipin-crosslinked dual-sensitive hydrogel/nanostructured lipid carrier ocular drug delivery platform
复制标题
混合京尼平交联双敏感水凝胶/纳米结构脂质载体眼部药物递送平台
DOI:
10.1016/j.ajps.2018.08.002
复制
发表时间:
2019
影响因子:
10.2
通讯作者:
Li Sanming
中科院分区:
文献类型:
--
作者:
Yu Yibin;Feng Ruoxi;Li Jinyu;Wang Yuanyuan;Song Yiming;Tan Guoxin;Liu D;an;Liu Wei;Yang Xinggang;Pan Hao;Li Sanming
The objective of this study was to develop a novel hybrid genipin-crosslinked dual-sensitive hydrogel/nanostructured lipid carrier (NLC) drug delivery platform. An ophthalmic anti-inflammatory drug, baicalin (BN) was chosen as the model drug. BNsingle bondNLC was prepared using melt-emulsification combined with ultra-sonication technique. Additionally, a dual pH- and thermo-sensitive hydrogel composed of carboxymethyl chitosan (CMCS) and poloxamer 407 (F127) was fabricated by a cross-linking reaction with a nontoxic crosslinker genipin (GP). GP-CMCS/F127 hydrogel was characterized by FTIR, NMR, XRD and SEM. The swelling studies showed GP-CMCS/F127 hydrogel was both pH- and thermo-sensitive. The results ofin vitrorelease suggested BNsingle bondNLC gel can prolong the release of baicalin comparing with BN eye drops and BNsingle bondNLC.Ex vivocornea permeation study was evaluated using Franz diffusion cells. The apparent permeability coefficient (Papp) of BNsingle bondNLC gel was much higher (4.46-fold) than that of BN eye drops. Through the determination of corneal hydration levels, BNsingle bondNLC gel was confirmed that had no significant irritation to cornea.Ex vivoprecorneal retention experiments were carried out by a flow-through approach. The results indicated that the NLC-based hydrogel can prolong precorneal residence time. In conclusion, the hybrid NLC-based hydrogel has a promising potential for application in ocular drug delivery.